Abstract
Cellular metabolic status profoundly influences Tcell differentiation, persistence, and anti-tumor efficacy. Our single-cell metabolic analyses of Tcells reveal that diminished mannose metabolism is a prominent feature of Tcell dysfunction. Conversely, experimental augmentation/restoration of mannose metabolism in adoptively transferred Tcells via D-mannose supplementation enhances anti-tumor activity and restricts exhaustion differentiation both invitro and invivo. Mechanistically, D-mannose treatment induces intracellular metabolic programming and increases the O-GlcNAc transferase (OGT)-mediated O-GlcNAcylation of β-catenin, which preserves Tcf7 expression and epigenetic stemness, thereby promoting stem-like programs in Tcells. Furthermore, invitro expansion with D-mannose supplementation yields Tcell products for adoptive therapy with stemness characteristics, even after extensive long-term expansion, that exhibits enhanced anti-tumor efficacy. These findings reveal cell-intrinsic mannose metabolism as a physiological regulator of CD8+ Tcell fate, decoupling proliferation/expansion from differentiation, and underscoring the therapeutic potential of mannose modulation in cancer immunotherapy.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
